🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers are looking for new ways to treat esophageal squamous cell carc...
Status
Recruiting
Location
UPMC Hillman Cancer Center ( Site 1904)
Start Date
2025-07-30
Trial ID
NCT06780111
Researchers are looking for new ways to treat metastatic nonsquamous non-sm...
Status
Recruiting
Location
University of Kentucky Chandler Medical Center ( Site 0019)
Start Date
2025-05-13
Trial ID
NCT06780085
Researchers are looking for new ways to treat metastatic castration-resista...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix ( Site 0044)
Start Date
2025-05-13
Trial ID
NCT06925737
Treatments Being Tested
The purpose of this substudy is to assess the efficacy and safety of ifinat...
Status
Recruiting
Location
UCLA Hematology & Oncology ( Site 0003)
Start Date
2025-07-03
Trial ID
NCT06863272
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of pembroliz...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0001)
Start Date
2019-12-19
Trial ID
NCT04165070
This study will investigate the maximum tolerated dose, the recommended dos...
Status
Active Not Recruiting
Location
Cedar-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
Start Date
2020-12-14
Trial ID
NCT04471727
Treatments Being Tested
This 2-part study intends to define the recommended Phase 2 dose of ifinata...
Status
Active Not Recruiting
Location
Highlands Oncology Group
Start Date
2022-03-09
Trial ID
NCT05280470
Treatments Being Tested
This study is designed to compare the efficacy and safety of I-DXd with tre...
Status
Recruiting
Location
Highlands Oncology Group
Start Date
2024-05-21
Trial ID
NCT06203210
Treatments Being Tested
This study is designed to assess the efficacy and safety of ifinatamab deru...
Status
Recruiting
Location
Valkyrie Clinical Trials
Start Date
2024-04-10
Trial ID
NCT06330064
Treatments Being Tested
This study is designed to assess the efficacy and safety of ifinatamab deru...
Status
Recruiting
Location
Mayo Clinic Hospital
Start Date
2025-03-27
Trial ID
NCT06644781
Treatments Being Tested